Sign In
Buy MBOT
$1.72
-0.0200 (-1.15%)
At Close: Jul 31, 2026
Microbot Medical Announces the Participation of a Key Opinion Leader in the Endovascular Robotics Space at the Next “Access-Ability Live by MBOT” Webinar Series
01:30pm, Wednesday, 14'th Dec 2022 GlobeNewswire Inc.
The Webinar, Which is Suitable to All Stakeholders Interested in the Future of Endovascular Robotics, Will be Held on Wednesday, December 21, 2022, at 1:00pm ET
Microbot Medical’s Proprietary LIBERTY® Robotic System Receives Third Patent Allowance in Israel
12:00pm, Thursday, 08'th Dec 2022 GlobeNewswire Inc.
Pace of Jurisdictional Allowances Parallels Pre-Clinical and Regulatory Progress Pace of Jurisdictional Allowances Parallels Pre-Clinical and Regulatory Progress
Microbot Medical Announces New Webinar Series to Engage Stakeholders with Experts in the Healthcare Space
12:00pm, Tuesday, 15'th Nov 2022 GlobeNewswire Inc.
The “Access-Ability Live” by MBOT will build an online community of healthcare industry leaders who are interested in robotics to come together and share their opinion and experience
Microbot Medical Receives Additional Patent Allowance in Israel for the LIBERTY® Robotic System
11:00am, Thursday, 03'rd Nov 2022 GlobeNewswire Inc.
Corresponding Application Previously Granted in the U.S. as the Company Continues to Create Global Barriers to Entry for its Novel Technology Corresponding Application Previously Granted in the U.S. a
Microbot Medical Adds the Head of the Interventional Radiology Unit of Europe’s Largest Cancer Center, Dr. Thierry Jacques De Baère to its Scientific Advisory Board
11:00am, Monday, 31'st Oct 2022 GlobeNewswire Inc.
Growing SAB Roster Includes 11 KOLs from Across the U.S., Europe, and Israel
Microbot Medical Accomplishes the Next-Step in the Regulatory Process for the LIBERTY® Robotic System
12:45pm, Tuesday, 18'th Oct 2022 GlobeNewswire Inc.
HINGHAM, Mass., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), announced that it has submitted the anticipated follow-up pre-submission package for the LIBERTY® Robotic Sys
Microbot Medical Completes GLP Animal Study for the LIBERTY® Robotic System
01:15pm, Thursday, 13'th Oct 2022 GlobeNewswire Inc.
HINGHAM, Mass., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced a significant development milestone as it completed the GLP animal study for the LIBERTY® Robotic Sy
Microbot Medical Receives Patent Allowance in Israel for the LIBERTY® Robotic System
11:00am, Monday, 10'th Oct 2022 GlobeNewswire Inc.
Complements Existing Allowance in the U.S. as Global Jurisdictions Recognize the Uniqueness of the Technology Complements Existing Allowance in the U.S. as Global Jurisdictions Recognize the Uniquenes
Microbot Medical Strengthens LIBERTY® Robotic System Portfolio with Acquisition of Novel FDA-Cleared Devices
12:36pm, Friday, 07'th Oct 2022 GlobeNewswire Inc.
Integration with the LIBERTY® Robotic System & One & Done™ Technology May Enable Future Acceleration of Robotic Adoption; Represents an Additional Growth Opportunity by Accessing the $500 Million C
Microbot Medical Announce Strategic Addition to Scientific Advisory Board Appointment
12:30pm, Tuesday, 04'th Oct 2022 GlobeNewswire Inc.
Award-Winning Interventional Radiologist in the NY Metro Area Adds Significant Depth and Experience Award-Winning Interventional Radiologist in the NY Metro Area Adds Significant Depth and Experience
Microbot Medical to Review Recent Progress During H.C. Wainwright’s 24th Annual Global Investment Conference
11:00am, Tuesday, 13'th Sep 2022 GlobeNewswire Inc.
Company Continues to Achieve Primary Objectives for its LIBERTY® Robotic System in 2022 Company Continues to Achieve Primary Objectives for its LIBERTY® Robotic System in 2022
Microbot Medical to Review Recent Progress During H.C. Wainwright's 24th Annual Global Investment Conference
07:00am, Tuesday, 13'th Sep 2022
Company Continues to Achieve Primary Objectives for its LIBERTY® Robotic System in 2022 Company Continues to Achieve Primary Objectives for its LIBERTY® Robotic System in 2022
Microbot Medical Strengthen its Scientific Advisory Board with the Recent Addition of Dr. Sebastian Flacke
11:00am, Thursday, 08'th Sep 2022 GlobeNewswire Inc.
A global leader in the endovascular space will collaborate with the Company as it goes through the regulatory process and future commercialization
Microbot Medical Confirms GLP Pre-Clinical Trial is on Track to Commence Later this Month
11:00am, Friday, 02'nd Sep 2022 GlobeNewswire Inc.
HINGHAM, Mass., Sept. 02, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced, as part of the preparation for its anticipated U.S. Food and Drug Administration (FDA) and CE Mark
Microbot Medical to Present the Self-Cleaning Shunt at the 16th Asian Australasian Congress of Neurological Surgeons
11:00am, Thursday, 18'th Aug 2022 GlobeNewswire Inc.
HINGHAM, Mass., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), announced that it will be presenting the Company’s Self-Cleaning Shunt (SCS) at the 16th Asian Australasian
